Evidence map›Paper›PMID 37405558›Full record

ReviewAnnals of biomedical engineering2023

Surgical Robotics for Intracerebral Hemorrhage Treatment: State of the Art and Future Directions.

Zhuojin Wu, Danyang Chen, Chao Pan, Ge Zhang, Shiling Chen, Jian Shi, Cai Meng, Xingwei Zhao, Bo Tao, Diansheng Chen and 3 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of biomedical engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Zhuojin Wu *Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Danyang Chen *Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Chao PanDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Ge ZhangDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Shiling ChenDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Jian ShiSchool of Mechanical Science & Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Cai MengSchool of Mechanical Engineering & Automation-BUAA, Beihang University, Beijing, 100083, China.
Xingwei ZhaoSchool of Mechanical Science & Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Bo TaoSchool of Mechanical Science & Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.
Diansheng ChenSchool of Mechanical Engineering & Automation-BUAA, Beihang University, Beijing, 100083, China.
Wenjie LiuBeijing WanTeFu Medical Instrument Co., Ltd, Beijing, 102299, China.
Han Ding *School of Mechanical Science & Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China. dinghan@hust.edu.cn.
Zhouping Tang *Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. ddjtzp@163.com.
Tongji Hospital · CNHuazhong University of Science and Technology · CNBeihang University · CNBeijing Wantai Biological Pharmacy (China) · CN

Funding

Hubei Provincial Department of Science & Technology 2021BCA109National Natural Science Foundation of China 92148206
6 · The paper itself

Abstract

Intracerebral hemorrhage (ICH) is a stroke subtype with high mortality and disability, and there are no proven medical treatments that can improve the functional outcome of ICH patients. Robot-assisted neurosurgery is a significant advancement in the development of minimally invasive surgery for ICH. This review encompasses the latest advances and future directions of surgical robots for ICH. First, three robotic systems for neurosurgery applied to ICH are illustrated. Second, the key technologies of robot-assisted surgery for ICH are introduced in aspects of stereotactic technique and navigation, the puncture instrument, and hematoma evacuation. Finally, the limitations of current surgical robots are summarized, and the possible development direction is discussed, which is named "multisensor fusion and intelligent aspiration control of minimally invasive surgical robot for ICH". It is expected that the new generation of surgical robots for ICH will facilitate quantitative, precise, individualized, standardized treatment strategies for ICH.

Indexed as

RoboticsCerebral HemorrhageHumansMinimally Invasive Surgical ProceduresNeurosurgical ProceduresTreatment OutcomeHematoma evacuationIntracerebral hemorrhageNavigationPerceptionPunctureRobot-assisted surgery

Identifiers

PMID37405558
PMCPMC10409846
OpenAlexW4383187218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.